| Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis (NCT05590247) | Ohio State University | 2022-07-21 |
| Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis (NCT05511519) | Aclaris Therapeutics, Inc. | 2022-07-12 |
| Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis (NCT04991116) | Sun Pharmaceutical Industries Limited | 2022-06-30 |
| Monitoring of Inflammatory Conditions (NCT05458531) | University of Nottingham | 2022-06-28 |
| Yuflyma® (Adalimumab), Patient Experience After Switching (NCT05427942) | Celltrion HealthCare France | 2022-06-03 |
| Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis (NCT04269993) | Brown University | 2022-05-18 |
| Accelerometry in Follow up of Arthritis - a Pilot Study (NCT05301621) | Helse Forde | 2022-05-12 |
| bIosimilar of aDalimumab, an European evAluation (NCT05190484) | Fresenius Kabi | 2022-04-30 |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors (NCT04751396) | M.D. Anderson Cancer Center | 2022-04-20 |
| Ticopa Serum Analysis: an Analysis of Blood Samples From the TICOPA Study (NCT05329896) | University of Leeds | 2022-04-01 |
| 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis (NCT05155098) | Novartis Pharmaceuticals | 2022-03-25 |
| Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis (NCT05291819) | Diakonhjemmet Hospital | 2022-03-14 |
| Stronger Together Psoriatic Arthritis Wellness Study (NCT05652608) | Global Healthy Living Foundation | 2022-03-01 |
| Medication Adherence in Psoriatic Arthritis (NCT05223062) | Bezmialem Vakif University | 2022-02-18 |
| Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP (NCT05215561) | Novartis Pharmaceuticals | 2022-02-14 |
| Survey About Diet in Chronic Inflammatory Rheumatic Diseases (NCT05283096) | Poitiers University Hospital | 2022-02-10 |
| Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesity (NCT05225623) | University of Calgary | 2022-02-01 |
| The Effects of Weight Loss on Psoriatic Arthritis (NCT05393141) | Hacettepe University | 2022-01-30 |
| Neuropathic Pain in Psoriatic Arthritis (NCT05223049) | Bezmialem Vakif University | 2022-01-22 |
| Psorcast Mobile Study (NCT05621369) | Sage Bionetworks | 2022-01-01 |
| COVID-19 VaccinE Response in Rheumatology Patients (NCT05080218) | Jeffrey Curtis | 2021-11-15 |
| A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis (NCT05195814) | Pfizer | 2021-11-15 |
| Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 (NCT05115370) | University of Nottingham | 2021-11-01 |
| Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis (NCT05055934) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-10-22 |
| Do Nanobubbles Improve Joint Hypoxia? (NCT04844008) | University of Oxford | 2021-10-05 |
| Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen (NCT04804449) | University of Oxford | 2021-10-04 |
| Biobank for Inflammatory Chronic Diseases and Osteoporosis (NCT05039216) | University Hospital, Toulouse | 2021-09-13 |
| To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis (NCT04957550) | Jiangsu HengRui Medicine Co., Ltd. | 2021-08-30 |
| Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases (NCT04922840) | Diakonhjemmet Hospital | 2021-08-09 |
| Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging (NCT05135312) | OptiSkin Medical | 2021-08-09 |
| An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients (NCT04967950) | Peking Union Medical College Hospital | 2021-07-15 |
| A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment (NCT04908189) | Bristol-Myers Squibb | 2021-07-15 |
| A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs (NCT04908202) | Bristol-Myers Squibb | 2021-07-13 |
| AsseSSing Impact in pSoriatic Treatment (NCT05171270) | University of Oxford | 2021-07-12 |
| Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. (NCT04711902) | Novartis Pharmaceuticals | 2021-06-24 |
| Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? (NCT04857476) | The Royal Wolverhampton Hospitals NHS Trust | 2021-06-22 |
| Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study (NCT05677542) | Novartis Pharmaceuticals | 2021-06-02 |
| Tapering of Biologics in Inflammatory Arthritis Patients in Remission (NCT04429776) | University of Manchester | 2021-05-13 |
| Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis (NCT05046431) | Bio-Thera Solutions | 2021-05-06 |
| SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE (NCT04417114) | Brigham and Women's Hospital | 2021-04-01 |
| PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis (NCT04176978) | Chinese University of Hong Kong | 2021-04-01 |
| The Diagnostic Ultrasound Enthesitis Tool (DUET) Study (NCT04587362) | Women's College Hospital | 2021-03-17 |
| Diet Interventions in Psoriatic Arthritis (NCT04180904) | University of Pennsylvania | 2021-03-11 |
| Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication (NCT04798625) | Diakonhjemmet Hospital | 2021-02-15 |
| COVID-19 Vaccination in Rheumatic Disease Patients (NCT04839315) | Mayo Clinic | 2021-02-15 |
| A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis (NCT04758117) | AbbVie | 2021-02-04 |
| Arthroscopic Synovectomy of the Wrist in Inflammatory Arthritis (NCT04755127) | Maasstad Hospital | 2021-01-01 |
| Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails (NCT04709354) | Bezmialem Vakif University | 2021-01-01 |
| Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment (NCT04632927) | Novartis Pharmaceuticals | 2020-12-21 |
| Monitoring Spondyloarthritis With SpA-Net (NCT04673825) | Maastricht University Medical Center | 2020-12-02 |
| Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases (NCT04655612) | University Hospital, Montpellier | 2020-12-01 |
| The MEDIPSA Clinical Trial (NCT04588623) | Medical University of Graz | 2020-11-25 |
| Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients (NCT04645420) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2020-11-12 |
| IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT (NCT04347798) | University of Alberta | 2020-11-01 |
| Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis (NCT04610476) | University of Erlangen-Nürnberg Medical School | 2020-10-19 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response (NCT05051943) | Fresenius Kabi | 2020-09-29 |
| Impact of Hyperuricemia on Psoriatic Arthritis (NCT06125444) | University Hospital, Strasbourg, France | 2020-08-24 |
| A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis (NCT04713072) | ACELYRIN Inc. | 2020-08-04 |
| Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement (NCT04062695) | Charite University, Berlin, Germany | 2020-08-04 |
| Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis (NCT04433442) | AbbVie | 2020-08-04 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis (NCT04341233) | NHS Lothian | 2020-08-01 |
| Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist (NCT04800289) | Centre Hospitalier le Mans | 2020-07-19 |
| Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA) (NCT04428502) | Pfizer | 2020-07-05 |
| Information and Acceptability of Biosimilars (NCT04321291) | University Hospital, Montpellier | 2020-07-02 |
| Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast (NCT04102449) | Medical University of Graz | 2020-07-01 |
| A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) (NCT04163016) | UCB Biopharma SRL | 2020-06-19 |
| Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis (NCT04402554) | University Hospital, Clermont-Ferrand | 2020-05-19 |
| PsA Secukinumab XCT Structural Progression Study (NCT03623867) | Chinese University of Hong Kong | 2020-05-18 |
| COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases (NCT04335747) | Salome Kristensen | 2020-04-23 |
| Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease (NCT04345159) | Fondation Ophtalmologique Adolphe de Rothschild | 2020-04-17 |
| Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic Arthritis (NCT04325724) | Assistance Publique - Hôpitaux de Paris | 2020-04-01 |
| Comparison of the Effectiveness of Functional Training Versus Resistance Exercises in Patients With Psoriatic Arthritis (NCT04304326) | Federal University of São Paulo | 2020-04-01 |
| Evaluating of New Screening Tool for Arthritis* in Psoriasis (NCT04277832) | Bezmialem Vakif University | 2020-02-21 |
| Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis (NCT04209205) | Novartis Pharmaceuticals | 2020-01-29 |
| Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases (NCT04200690) | University of Aarhus | 2020-01-14 |
| TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study (NCT04261010) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2020-01-14 |
| GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden (NCT04190758) | Vastra Gotaland Region | 2020-01-01 |
| Evolution and Treatments of Chronic Inflammatory Systemic Diseases (NCT04191395) | Centre Hospitalier Universitaire de Besancon | 2019-12-11 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy (NCT04115748) | Gilead Sciences | 2019-12-03 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy (NCT04115839) | Gilead Sciences | 2019-11-13 |
| Impact of Decision-Framing in Psoriasis (NCT04136314) | University of Southern California | 2019-10-21 |
| Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK) (NCT04602091) | Societe Francaise de Rhumatologie | 2019-10-08 |
| Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies. (NCT05767814) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-10-03 |
| Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic Arthritis (NCT04553302) | Melissa Köprülüoğlu | 2019-10-01 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects (NCT04152759) | Bio-Thera Solutions | 2019-09-09 |
| Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis (NCT04426747) | Groupe Hospitalier Pitie-Salpetriere | 2019-09-01 |
| Yoga-mindfulness for Pain Management in Inflammatory Arthritis (NCT04065958) | Karolinska Institutet | 2019-08-19 |
| A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis (NCT04109976) | UCB Biopharma SRL | 2019-08-13 |
| A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (NCT04009499) | UCB Biopharma SRL | 2019-08-13 |
| Psoriatic Arthritis D2P Screening (NCT04110522) | Jessica Walsh | 2019-07-22 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS (NCT04018599) | Fresenius Kabi SwissBioSim GmbH | 2019-07-15 |
| Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis (NCT05128500) | Permedica spa | 2019-07-12 |
| Effect of Custom Foot Orthoses in Patients With Psoriatic Arthritis (NCT05075343) | Patrick Boissy | 2019-07-01 |
| A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register (NCT05413044) | Bristol-Myers Squibb | 2019-07-01 |
| A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis (NCT03963401) | Pfizer | 2019-06-13 |
| Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (NCT03816917) | Radboud University Medical Center | 2019-06-01 |
| Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System (NCT03986918) | Ortho Development Corporation | 2019-06-01 |